{"id":"https://openalex.org/W4281385652","doi":"https://doi.org/10.1158/1078-0432.ccr-21-3867","title":"Selinexor Combined with Ibrutinib Demonstrates Tolerability and Safety in Advanced B-Cell Malignancies: A Phase I Study","display_name":"Selinexor Combined with Ibrutinib Demonstrates Tolerability and Safety in Advanced B-Cell Malignancies: A Phase I Study","publication_year":2022,"publication_date":"2022-05-24","ids":{"openalex":"https://openalex.org/W4281385652","doi":"https://doi.org/10.1158/1078-0432.ccr-21-3867","pmid":"https://pubmed.ncbi.nlm.nih.gov/35608822","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/9364840"},"language":"en","primary_location":{"id":"doi:10.1158/1078-0432.ccr-21-3867","doi":"https://doi.org/10.1158/1078-0432.ccr-21-3867","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1078-0432.ccr-21-3867","pdf_url":"https://aacrjournals.org/clincancerres/article-pdf/28/15/3242/3181404/3242.pdf","source":{"id":"https://openalex.org/S183149254","display_name":"Clinical Cancer Research","issn_l":"1078-0432","issn":["1078-0432","1557-3265"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Cancer Research","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://aacrjournals.org/clincancerres/article-pdf/28/15/3242/3181404/3242.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5031412066","display_name":"Deborah Marie Stephens","orcid":"https://orcid.org/0000-0001-9188-5008","observed_orcids":["https://orcid.org/0000-0001-9188-5008"]},"institutions":[{"id":"https://openalex.org/I223532165","display_name":"University of Utah","ror":"https://ror.org/03r0ha626","country_code":"US","type":"education","lineage":["https://openalex.org/I223532165"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Deborah M. Stephens","raw_affiliation_strings":["1University of Utah, Salt Lake City, Utah"],"raw_orcid":"https://orcid.org/0000-0001-9188-5008","affiliations":[{"raw_affiliation_string":"1University of Utah, Salt Lake City, Utah","institution_ids":["https://openalex.org/I223532165"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5082021894","display_name":"Ying Huang","orcid":"https://orcid.org/0000-0001-9910-1212","observed_orcids":["https://orcid.org/0000-0001-9910-1212","https://orcid.org/0009-0002-6227-4755"]},"institutions":[{"id":"https://openalex.org/I52357470","display_name":"The Ohio State University","ror":"https://ror.org/00rs6vg23","country_code":"US","type":"education","lineage":["https://openalex.org/I52357470"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ying Huang","raw_affiliation_strings":["2Ohio State University, Columbus, Ohio"],"raw_orcid":"https://orcid.org/0000-0001-9910-1212","affiliations":[{"raw_affiliation_string":"2Ohio State University, Columbus, Ohio","institution_ids":["https://openalex.org/I52357470"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109829305","display_name":"Amy S. Ruppert","orcid":"https://orcid.org/0000-0001-9612-6473","observed_orcids":["https://orcid.org/0000-0001-9612-6473"]},"institutions":[{"id":"https://openalex.org/I52357470","display_name":"The Ohio State University","ror":"https://ror.org/00rs6vg23","country_code":"US","type":"education","lineage":["https://openalex.org/I52357470"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Amy S. Ruppert","raw_affiliation_strings":["2Ohio State University, Columbus, Ohio"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Ohio State University, Columbus, Ohio","institution_ids":["https://openalex.org/I52357470"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5063266976","display_name":"Janek S. Walker","orcid":"https://orcid.org/0000-0002-2049-1527","observed_orcids":["https://orcid.org/0000-0002-2049-1527"]},"institutions":[{"id":"https://openalex.org/I52357470","display_name":"The Ohio State University","ror":"https://ror.org/00rs6vg23","country_code":"US","type":"education","lineage":["https://openalex.org/I52357470"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Janek S. Walker","raw_affiliation_strings":["2Ohio State University, Columbus, Ohio"],"raw_orcid":"https://orcid.org/0000-0002-2049-1527","affiliations":[{"raw_affiliation_string":"2Ohio State University, Columbus, Ohio","institution_ids":["https://openalex.org/I52357470"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5019455562","display_name":"Daniel Canfield","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I52357470","display_name":"The Ohio State University","ror":"https://ror.org/00rs6vg23","country_code":"US","type":"education","lineage":["https://openalex.org/I52357470"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Daniel Canfield","raw_affiliation_strings":["2Ohio State University, Columbus, Ohio"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Ohio State University, Columbus, Ohio","institution_ids":["https://openalex.org/I52357470"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5028386076","display_name":"Casey B. Cempre","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I52357470","display_name":"The Ohio State University","ror":"https://ror.org/00rs6vg23","country_code":"US","type":"education","lineage":["https://openalex.org/I52357470"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Casey B. Cempre","raw_affiliation_strings":["2Ohio State University, Columbus, Ohio"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Ohio State University, Columbus, Ohio","institution_ids":["https://openalex.org/I52357470"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5050220993","display_name":"Qiang Fu","orcid":"https://orcid.org/0000-0001-7136-5849","observed_orcids":["https://orcid.org/0000-0001-7136-5849"]},"institutions":[{"id":"https://openalex.org/I52357470","display_name":"The Ohio State University","ror":"https://ror.org/00rs6vg23","country_code":"US","type":"education","lineage":["https://openalex.org/I52357470"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Qiang Fu","raw_affiliation_strings":["2Ohio State University, Columbus, Ohio"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Ohio State University, Columbus, Ohio","institution_ids":["https://openalex.org/I52357470"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5077260725","display_name":"Sharyn D. Baker","orcid":"https://orcid.org/0000-0003-3062-3252","observed_orcids":["https://orcid.org/0000-0003-3062-3252"]},"institutions":[{"id":"https://openalex.org/I52357470","display_name":"The Ohio State University","ror":"https://ror.org/00rs6vg23","country_code":"US","type":"education","lineage":["https://openalex.org/I52357470"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Sharyn Baker","raw_affiliation_strings":["2Ohio State University, Columbus, Ohio"],"raw_orcid":"https://orcid.org/0000-0003-3062-3252","affiliations":[{"raw_affiliation_string":"2Ohio State University, Columbus, Ohio","institution_ids":["https://openalex.org/I52357470"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5024273516","display_name":"Boyu Hu","orcid":"https://orcid.org/0000-0001-9848-9497","observed_orcids":["https://orcid.org/0000-0001-9848-9497"]},"institutions":[{"id":"https://openalex.org/I223532165","display_name":"University of Utah","ror":"https://ror.org/03r0ha626","country_code":"US","type":"education","lineage":["https://openalex.org/I223532165"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Boyu Hu","raw_affiliation_strings":["1University of Utah, Salt Lake City, Utah"],"raw_orcid":"https://orcid.org/0000-0001-9848-9497","affiliations":[{"raw_affiliation_string":"1University of Utah, Salt Lake City, Utah","institution_ids":["https://openalex.org/I223532165"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5011348837","display_name":"Harsh Shah","orcid":"https://orcid.org/0000-0001-6054-5238","observed_orcids":["https://orcid.org/0000-0001-6054-5238"]},"institutions":[{"id":"https://openalex.org/I223532165","display_name":"University of Utah","ror":"https://ror.org/03r0ha626","country_code":"US","type":"education","lineage":["https://openalex.org/I223532165"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Harsh Shah","raw_affiliation_strings":["1University of Utah, Salt Lake City, Utah"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1University of Utah, Salt Lake City, Utah","institution_ids":["https://openalex.org/I223532165"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5079332929","display_name":"Renee Vadeboncoeur","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I223532165","display_name":"University of Utah","ror":"https://ror.org/03r0ha626","country_code":"US","type":"education","lineage":["https://openalex.org/I223532165"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Renee Vadeboncoeur","raw_affiliation_strings":["1University of Utah, Salt Lake City, Utah"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1University of Utah, Salt Lake City, Utah","institution_ids":["https://openalex.org/I223532165"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5042260558","display_name":"Kerry Anne Rogers","orcid":"https://orcid.org/0000-0001-5748-7874","observed_orcids":["https://orcid.org/0000-0001-5748-7874"]},"institutions":[{"id":"https://openalex.org/I52357470","display_name":"The Ohio State University","ror":"https://ror.org/00rs6vg23","country_code":"US","type":"education","lineage":["https://openalex.org/I52357470"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kerry A. Rogers","raw_affiliation_strings":["2Ohio State University, Columbus, Ohio"],"raw_orcid":"https://orcid.org/0000-0001-5748-7874","affiliations":[{"raw_affiliation_string":"2Ohio State University, Columbus, Ohio","institution_ids":["https://openalex.org/I52357470"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5050724356","display_name":"Seema Ali Bhat","orcid":"https://orcid.org/0000-0001-7844-0856","observed_orcids":["https://orcid.org/0000-0001-7844-0856"]},"institutions":[{"id":"https://openalex.org/I52357470","display_name":"The Ohio State University","ror":"https://ror.org/00rs6vg23","country_code":"US","type":"education","lineage":["https://openalex.org/I52357470"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Seema Bhat","raw_affiliation_strings":["2Ohio State University, Columbus, Ohio"],"raw_orcid":"https://orcid.org/0000-0001-7844-0856","affiliations":[{"raw_affiliation_string":"2Ohio State University, Columbus, Ohio","institution_ids":["https://openalex.org/I52357470"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5072835425","display_name":"Samantha Mary Jaglowski","orcid":"https://orcid.org/0000-0002-4335-2554","observed_orcids":["https://orcid.org/0000-0002-4335-2554"]},"institutions":[{"id":"https://openalex.org/I52357470","display_name":"The Ohio State University","ror":"https://ror.org/00rs6vg23","country_code":"US","type":"education","lineage":["https://openalex.org/I52357470"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Samantha M. Jaglowski","raw_affiliation_strings":["2Ohio State University, Columbus, Ohio"],"raw_orcid":"https://orcid.org/0000-0002-4335-2554","affiliations":[{"raw_affiliation_string":"2Ohio State University, Columbus, Ohio","institution_ids":["https://openalex.org/I52357470"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5078286506","display_name":"Hank A. Lockman","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I52357470","display_name":"The Ohio State University","ror":"https://ror.org/00rs6vg23","country_code":"US","type":"education","lineage":["https://openalex.org/I52357470"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Hank Lockman","raw_affiliation_strings":["2Ohio State University, Columbus, Ohio"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Ohio State University, Columbus, Ohio","institution_ids":["https://openalex.org/I52357470"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5023800287","display_name":"Rosa Lapalombella","orcid":"https://orcid.org/0000-0001-6916-9400","observed_orcids":["https://orcid.org/0000-0001-6916-9400"]},"institutions":[{"id":"https://openalex.org/I52357470","display_name":"The Ohio State University","ror":"https://ror.org/00rs6vg23","country_code":"US","type":"education","lineage":["https://openalex.org/I52357470"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Rosa Lapalombella","raw_affiliation_strings":["2Ohio State University, Columbus, Ohio"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Ohio State University, Columbus, Ohio","institution_ids":["https://openalex.org/I52357470"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5000921376","display_name":"John C. Byrd","orcid":"https://orcid.org/0000-0001-9830-0711","observed_orcids":["https://orcid.org/0000-0001-9830-0711"]},"institutions":[{"id":"https://openalex.org/I52357470","display_name":"The Ohio State University","ror":"https://ror.org/00rs6vg23","country_code":"US","type":"education","lineage":["https://openalex.org/I52357470"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"John C. Byrd","raw_affiliation_strings":["2Ohio State University, Columbus, Ohio"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Ohio State University, Columbus, Ohio","institution_ids":["https://openalex.org/I52357470"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5014241029","display_name":"Jennifer Ann Woyach","orcid":"https://orcid.org/0000-0002-3403-9144","observed_orcids":["https://orcid.org/0000-0002-3403-9144"]},"institutions":[{"id":"https://openalex.org/I52357470","display_name":"The Ohio State University","ror":"https://ror.org/00rs6vg23","country_code":"US","type":"education","lineage":["https://openalex.org/I52357470"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jennifer A. Woyach","raw_affiliation_strings":["2Ohio State University, Columbus, Ohio"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Ohio State University, Columbus, Ohio","institution_ids":["https://openalex.org/I52357470"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5031412066"],"corresponding_institution_ids":["https://openalex.org/I223532165"],"apc_list":null,"apc_paid":null,"fwci":3.7269,"has_fulltext":true,"cited_by_count":29,"citation_normalized_percentile":{"value":0.94777397,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":95,"max":99},"biblio":{"volume":"28","issue":"15","first_page":"3242","last_page":"3247"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11157","display_name":"Chronic Lymphocytic Leukemia Research","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics (clinical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11157","display_name":"Chronic Lymphocytic Leukemia Research","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics (clinical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10185","display_name":"Lymphoma Diagnosis and Treatment","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12534","display_name":"Protein Degradation and Inhibitors","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/selinexor","display_name":"selinexor","score":0.9980000257492065},{"id":"https://openalex.org/keywords/ibrutinib","display_name":"ibrutinib","score":0.9980000257492065},{"id":"https://openalex.org/keywords/bruton-s-tyrosine-kinase-inhibition","display_name":"Bruton's tyrosine kinase inhibition","score":0.890999972820282},{"id":"https://openalex.org/keywords/chronic-lymphocytic-leukemia","display_name":"chronic lymphocytic leukemia","score":0.9139999747276306},{"id":"https://openalex.org/keywords/non-hodgkin-lymphoma","display_name":"non-Hodgkin lymphoma","score":0.9990000128746033},{"id":"https://openalex.org/keywords/richter-transformation","display_name":"Richter transformation","score":0.824999988079071},{"id":"https://openalex.org/keywords/diffuse-large-b-cell-lymphoma","display_name":"diffuse large B-cell lymphoma","score":0.9440000057220459},{"id":"https://openalex.org/keywords/mantle-cell-lymphoma","display_name":"mantle cell lymphoma","score":0.9990000128746033},{"id":"https://openalex.org/keywords/relapsed-refractory-b-cell-malignancies","display_name":"relapsed/refractory B-cell malignancies","score":0.8859999775886536},{"id":"https://openalex.org/keywords/combination-therapy","display_name":"combination therapy","score":0.7390000224113464},{"id":"https://openalex.org/keywords/maximum-tolerated-dose","display_name":"maximum tolerated dose","score":0.8550000190734863},{"id":"https://openalex.org/keywords/safety-and-tolerability","display_name":"safety and tolerability","score":0.8320000171661377},{"id":"https://openalex.org/keywords/progression-free-survival","display_name":"progression-free survival","score":0.9509999752044678},{"id":"https://openalex.org/keywords/overall-survival","display_name":"overall survival","score":0.8880000114440918}],"concepts":[{"id":"https://openalex.org/C2779878957","wikidata":"https://www.wikidata.org/wiki/Q5984881","display_name":"Ibrutinib","level":4,"score":0.9734637141227722},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8223264217376709},{"id":"https://openalex.org/C2778375690","wikidata":"https://www.wikidata.org/wiki/Q7814214","display_name":"Tolerability","level":3,"score":0.7648789286613464},{"id":"https://openalex.org/C2777525834","wikidata":"https://www.wikidata.org/wiki/Q268713","display_name":"Mantle cell lymphoma","level":3,"score":0.7601606845855713},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.7004703879356384},{"id":"https://openalex.org/C2777938653","wikidata":"https://www.wikidata.org/wiki/Q1088156","display_name":"Chronic lymphocytic leukemia","level":3,"score":0.5714336037635803},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.5421068072319031},{"id":"https://openalex.org/C2779338263","wikidata":"https://www.wikidata.org/wiki/Q208414","display_name":"Lymphoma","level":2,"score":0.4923146963119507},{"id":"https://openalex.org/C2780580376","wikidata":"https://www.wikidata.org/wiki/Q186889","display_name":"Nausea","level":2,"score":0.4676228165626526},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.4653087258338928},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.4597148895263672},{"id":"https://openalex.org/C2778461978","wikidata":"https://www.wikidata.org/wiki/Q29496","display_name":"Leukemia","level":2,"score":0.2798421382904053}],"mesh":[{"descriptor_ui":"D000225","descriptor_name":"Adenine","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006834","descriptor_name":"Hydrazines","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008228","descriptor_name":"Lymphoma, Non-Hodgkin","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D010880","descriptor_name":"Piperidines","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011720","descriptor_name":"Pyrazoles","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D011743","descriptor_name":"Pyrimidines","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D014230","descriptor_name":"Triazoles","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015451","descriptor_name":"Leukemia, Lymphocytic, Chronic, B-Cell","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D016403","descriptor_name":"Lymphoma, Large B-Cell, Diffuse","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true}],"locations_count":3,"locations":[{"id":"doi:10.1158/1078-0432.ccr-21-3867","doi":"https://doi.org/10.1158/1078-0432.ccr-21-3867","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1078-0432.ccr-21-3867","pdf_url":"https://aacrjournals.org/clincancerres/article-pdf/28/15/3242/3181404/3242.pdf","source":{"id":"https://openalex.org/S183149254","display_name":"Clinical Cancer Research","issn_l":"1078-0432","issn":["1078-0432","1557-3265"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Cancer Research","raw_type":"journal-article"},{"id":"pmid:35608822","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/35608822","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical cancer research : an official journal of the American Association for Cancer Research","raw_type":"Clinical Trial, Phase I"},{"id":"pmh:oai:pubmedcentral.nih.gov:9364840","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/9364840","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"Clin Cancer Res","raw_type":"Text"}],"best_oa_location":{"id":"doi:10.1158/1078-0432.ccr-21-3867","doi":"https://doi.org/10.1158/1078-0432.ccr-21-3867","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1078-0432.ccr-21-3867","pdf_url":"https://aacrjournals.org/clincancerres/article-pdf/28/15/3242/3181404/3242.pdf","source":{"id":"https://openalex.org/S183149254","display_name":"Clinical Cancer Research","issn_l":"1078-0432","issn":["1078-0432","1557-3265"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Cancer Research","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"study_designs":[{"id":"https://openalex.org/study-designs/clinical-trial","display_name":"Clinical Trial"}],"awards":[{"id":"https://openalex.org/G1215644595","display_name":null,"funder_award_id":"CDP 2331\u201020","funder_id":"https://openalex.org/F4320308295","funder_display_name":"Leukemia and Lymphoma Society"},{"id":"https://openalex.org/G1540183218","display_name":"NRSA Training Core","funder_award_id":"TL1TR002735","funder_id":"https://openalex.org/F4320332161","funder_display_name":"National Institutes of Health"},{"id":"https://openalex.org/G1858189645","display_name":null,"funder_award_id":"P30CA016058","funder_id":"https://openalex.org/F4320309374","funder_display_name":"Ohio State University"},{"id":"https://openalex.org/G2560578072","display_name":"Targeted Therapy for Leukemia","funder_award_id":"R35CA197734","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"},{"id":"https://openalex.org/G3015188539","display_name":null,"funder_award_id":"/ NCI R01","funder_id":"https://openalex.org/F4320332161","funder_display_name":"National Institutes of Health"},{"id":"https://openalex.org/G36614667","display_name":null,"funder_award_id":"CA016058","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"},{"id":"https://openalex.org/G3703234395","display_name":"Dual targeting of XPO1 and BTK in B cell malignancies","funder_award_id":"R01CA192928","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"},{"id":"https://openalex.org/G6534654515","display_name":null,"funder_award_id":"CA197734","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"},{"id":"https://openalex.org/G6877035593","display_name":"Novel Strategies to Eliminate Resistance to B-cell Receptor Inhibitor Therapy in Lymphoid Malignancies","funder_award_id":"K23CA212271","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"},{"id":"https://openalex.org/G8945945924","display_name":null,"funder_award_id":"F31 CA261139","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"},{"id":"https://openalex.org/G9000266250","display_name":null,"funder_award_id":"CA016058","funder_id":"https://openalex.org/F4320332161","funder_display_name":"National Institutes of Health"},{"id":"https://openalex.org/G9000887552","display_name":"Cancer Center Support Grant","funder_award_id":"P30CA016058","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"},{"id":"https://openalex.org/G9000895941","display_name":"The Chesapeake-Ohio Pharmacokinetics Core for The ETCTN","funder_award_id":"U24CA247648","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"}],"funders":[{"id":"https://openalex.org/F4320308295","display_name":"Leukemia and Lymphoma Society","ror":"https://ror.org/04m0xav37"},{"id":"https://openalex.org/F4320309374","display_name":"Ohio State University","ror":"https://ror.org/00rs6vg23"},{"id":"https://openalex.org/F4320332161","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88"},{"id":"https://openalex.org/F4320337351","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81"},{"id":"https://openalex.org/F4320337472","display_name":"National Center for Advancing Translational Sciences","ror":"https://ror.org/04pw6fb54"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4281385652.pdf","grobid_xml":"https://content.openalex.org/works/W4281385652.grobid-xml"},"referenced_works_count":20,"referenced_works":["https://openalex.org/W324951808","https://openalex.org/W1020989877","https://openalex.org/W1979816280","https://openalex.org/W1987530377","https://openalex.org/W1993192840","https://openalex.org/W1999128869","https://openalex.org/W2046497407","https://openalex.org/W2055393972","https://openalex.org/W2071549499","https://openalex.org/W2078274740","https://openalex.org/W2112023756","https://openalex.org/W2154066874","https://openalex.org/W2154691188","https://openalex.org/W2171771895","https://openalex.org/W2610540653","https://openalex.org/W2984880931","https://openalex.org/W3012934148","https://openalex.org/W3037697670","https://openalex.org/W3134524629","https://openalex.org/W3185756680"],"related_works":["https://openalex.org/W2988532607","https://openalex.org/W2055393972","https://openalex.org/W2570921003","https://openalex.org/W167055487","https://openalex.org/W100713916","https://openalex.org/W2078131946","https://openalex.org/W2108350075","https://openalex.org/W3013074397","https://openalex.org/W1966315656","https://openalex.org/W2785269911"],"abstract_inverted_index":{"PURPOSE:":[0],"Dual":[1],"blockade":[2],"of":[3,115,252],"Bruton's":[4],"tyrosine":[5],"kinase":[6],"with":[7,18,39,168,188,216,232,244,246,264],"ibrutinib":[8,56,225,267],"and":[9,23,53,91,104,121,137,140,170,179,209,218,224],"selinexor":[10,52,116,223],"has":[11,227],"potential":[12],"to":[13,42,67,160,259],"deepen":[14,260],"responses":[15,239],"for":[16,166,214],"patients":[17,38,72,167,187,215,231,243,263],"chronic":[19],"lymphocytic":[20],"leukemia":[21],"(CLL)":[22],"non-Hodgkin":[24],"lymphoma":[25],"(NHL).":[26],"PATIENTS":[27],"AND":[28],"METHODS:":[29],"In":[30],"this":[31,253],"phase":[32],"I":[33],"study":[34,251],"(clinicaltrials.gov:":[35],"NCT02303392),":[36],"adult":[37],"CLL/NHL,":[40],"relapsed/refractory":[41,233],"\u22651":[43],"prior":[44,97,194,248],"therapy":[45],"were":[46,99,130,141,236,240],"enrolled.":[47],"Patients":[48],"received":[49,107],"weekly":[50],"oral":[51,55],"daily":[54,124],"in":[57,230,242,262],"28-day":[58],"cycles":[59],"until":[60],"progression":[61],"or":[62,78],"intolerance.":[63],"Primary":[64],"objective":[65],"was":[66,112,148,172,204],"determine":[68],"MTD.":[69],"RESULTS:":[70],"Included":[71],"had":[73],"CLL":[74,169,189,217,245,265],"(n":[75,80],"=":[76,81,102],"16)":[77],"NHL":[79,171],"18;":[82],"9":[83],"Richter":[84],"transformation,":[85],"6":[86],"diffuse":[87],"large":[88],"B-cell":[89],"lymphoma,":[90],"3":[92],"mantle":[93],"cell":[94],"lymphoma).":[95],"Median":[96,163],"therapies":[98],"4":[100],"(range":[101],"1-14)":[103],"59%":[105],"previously":[106],"ibrutinib.":[108,125],"The":[109,222],"established":[110],"MTD":[111],"40":[113],"mg":[114,123],"(days":[117],"1,":[118],"8,":[119],"15)":[120],"420":[122],"Common":[126],"nonhematologic":[127],"adverse":[128],"events":[129],"fatigue":[131],"(56%),":[132],"nausea":[133],"(53%),":[134],"anorexia":[135],"(41%),":[136],"diarrhea":[138],"(41%)":[139],"mostly":[142],"low":[143],"grade.":[144],"Overall":[145],"response":[146],"rate":[147],"32%.":[149],"An":[150],"additional":[151],"47%":[152],"achieved":[153],"stable":[154],"disease":[155],"(SD),":[156],"some":[157],"prolonged":[158],"(up":[159],"36":[161],"months).":[162],"progression-free":[164],"survival":[165,203],"8.9":[173],"[95%":[174],"confidence":[175],"interval":[176],"(CI),":[177],"3.9-16.1]":[178],"2.7":[180],"(95%":[181,206,211],"CI,":[182,207,212],"0.7-5.4)":[183],"months,":[184],"respectively.":[185,220],"For":[186],"who":[190],"did":[191],"not":[192],"receive":[193],"ibrutinib,":[195],"only":[196],"20%":[197],"(1/5)":[198],"progressed.":[199],"Estimated":[200],"2-year":[201],"overall":[202],"73.7%":[205],"44.1-89.2)":[208],"27.8%":[210],"10.1-48.9)":[213],"NHL,":[219],"CONCLUSIONS:":[221],"combination":[226,254],"demonstrated":[228],"tolerability":[229],"CLL/NHL.":[234],"Responses":[235],"durable.":[237],"Notable":[238],"seen":[241],"minimal":[247],"therapy.":[249,268],"Future":[250],"will":[255],"focus":[256],"on":[257],"efforts":[258],"remissions":[261],"receiving":[266]},"counts_by_year":[{"year":2026,"cited_by_count":4},{"year":2025,"cited_by_count":3},{"year":2024,"cited_by_count":5},{"year":2023,"cited_by_count":13},{"year":2022,"cited_by_count":3}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2022-05-25T00:00:00"}